Intended Purpose; Indication; Intended Use; Contraindications - Pari eflow rapid Instructions For Use Manual

Intended purpose

®
The eFlow rapid nebuliser system is
intended to administer solutions or
suspensions for a nebuliser handset as
an aerosol for inhalation.

Indication

®
The eFlow rapid nebuliser system is
intended to administer solutions or
suspensions for a nebuliser handset
which are approved for the treatment of
diseases of the lower airways.

Intended use

The nebuliser system must only be used
in accordance with its intended purpose.
The frequency of inhalation sessions may
vary depending on the nebuliser solution
or suspension used for a nebuliser hand-
set and the clinical picture. Take note of
any limitations in the package leaflet
accompanying the respective solution or
suspension for a nebuliser handset.
WARNING:
For reasons of hygiene and to avoid
cross-infections, the eFlow
nebuliser handset and the connection
cord must be used by one patient only.
For patients at greater risk of infection,
e.g., with cystic fibrosis (CF) or a weak-
ened immune system, or for those
infected with MRSA it is recommended
®
that the eBase Controller and the power
adapter are also used by one patient only.
8
®
rapid
Info:
®
The eBase Controller can also be
used for a drug-specific nebuliser
handset (Tolero
®
Altera
). Follow the instructions for
use of the nebuliser handset as well.
CAUTION:
Medications that are approved for inhala-
tion with a drug-specific nebuliser handset
must not be used with an eFlow
nebuliser handset (risk of incorrect
dosage).
CAUTION:
Never attempt to inhale essential oils, as
this can cause irritation of the airways
(intense coughing).
Only original PARI accessories must be
used to operate the system (see "SPARE
PARTS AND ACCESSORIES", page 26).
CAUTION:
Using accessories and spare parts other
than those supplied by the manufacturer
may cause increased electromagnetic
emissions or reduced electromagnetic
immunity, leading to a malfunction.
PARI Pharma GmbH is not responsible
for damage if the system is used improp-
erly or contrary to the instructions.

Contraindications

®
For the eFlow rapid nebuliser system no
contraindication is known to
PARI Pharma GmbH. Take note of
contraindications of the medicine in the
accompanying package leaflet.
® ®
, Zirela
and
®
rapid
®
eFlow rapid - 2022-07